Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...

Please provide your email address to receive an email when new articles are posted on . The onset of the COVID-19 pandemic forced health care systems to adapt clinical practice to limit patient ...

Exemption of the system from virtually all CLIA rules gives more labs access to connectivity and data management capabilities for monitoring patients on warfarin therapy INDIANAPOLIS, Oct. 1, 2012 ...

FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense ® PT/INR ...

Toronto, ON - Substitution of generic warfarin for brand-name warfarin (Coumadin, Bristol-Myers Squibb) has no appreciable effect on rates of INR testing or hospitalization for adverse events, a new ...